JD Health International Inc.
JDHIF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $35 | $30 | $28 | $26 |
| % Growth | 18.4% | 5.2% | 7.3% | – |
| Cost of Goods Sold | $26 | $23 | $22 | $21 |
| Gross Profit | $9 | $7 | $7 | $6 |
| % Margin | 25.2% | 22.2% | 23.6% | 21.4% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $1 | $1 | $1 | $1 |
| SG&A Expenses | $6 | $6 | $5 | $5 |
| Sales & Mktg Exp. | $2 | $2 | $1 | $1 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $7 | $6 | $6 | $6 |
| Operating Income | $2 | $0 | $1 | -$0 |
| % Margin | 6% | 0.4% | 3.7% | -0.9% |
| Other Income/Exp. Net | $1 | $2 | $1 | $1 |
| Pre-Tax Income | $3 | $2 | $2 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $3 | $2 | $2 | $1 |
| % Margin | 7.4% | 7.1% | 7.2% | 2.2% |
| EPS | 0.82 | 0.68 | 0.65 | 0.18 |
| % Growth | 20.6% | 4.6% | 261.1% | – |
| EPS Diluted | 0.81 | 0.67 | 0.65 | 0.18 |
| Weighted Avg Shares Out | 3 | 3 | 3 | 3 |
| Weighted Avg Shares Out Dil | 3 | 3 | 3 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | -$0 | $2 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $2 | $0 | $1 | -$0 |
| % Margin | 6.4% | 0.8% | 4% | -0% |